Existing drug treatments
Until recently, there were no effective drug treatments for idiopathic pulmonary fibrosis. But now there are two anti-fibrotic drugs pirfenidone and nintedanib which slow the progression of the disease in some patients.
If the cause of your pulmonary fibrosis is known, there are treatments. These may stop the disease but cannot reverse the scarring or cure it.
New drug treatments
There is also a pipeline of other anti-fibrotic drugs being developed, some of which may become available in the next few years. Find out about research studies taking place now.
Additionally, research is being undertaken on genetics and basic science, which we hope will lead to further improvements in treatment in years to come.
Action for Pulmonary Fibrosis is a leading research-funder in the UK. Our wish is that through funded research it will be possible, in the not too distant future, to stop progression of the disease soon after it has been diagnosed using pharmaceutical drugs and other treatments.
Information provided by Action for Pulmonary Fibrosis (APF) is not a substitute for professional medical advice. It’s intended as general information only. APF is not responsible for any errors or omissions or for any loss or damage suffered by users resulting from the information published on actionpf.org.
Further information for carers:
